Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Ferguson
FERG
|
+$740M |
| 2 |
Uber
UBER
|
+$498M |
| 3 |
DexCom
DXCM
|
+$449M |
| 4 |
Meta Platforms (Facebook)
META
|
+$312M |
| 5 |
Autodesk
ADSK
|
+$305M |
Top Sells
| 1 |
Salesforce
CRM
|
+$1.28B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
PayPal
PYPL
|
+$610M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
Accenture
ACN
|
+$391M |
Sector Composition
| 1 | Technology | 30.51% |
| 2 | Healthcare | 19.12% |
| 3 | Consumer Discretionary | 11.48% |
| 4 | Financials | 10.31% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Repligen
RGEN
$6.74B
| $6.23M | ﹤0.01% |
32,025
+9,186
| +40% | +$1.79M |
|
977
John Wiley & Sons Class A
WLY
$2.21B
| $6.2M | ﹤0.01% |
+114,455
| New | +$6.2M |
|
978
CenterPoint Energy
CNP
$24.7B
| $6.06M | ﹤0.01% |
267,741
+15,352
| +6% | +$348K |
|
|
CGC
979
Canopy Growth
CGC
$434M
| $6.03M | ﹤0.01% |
18,792
+13,139
| +232% | +$4.22M |
|
|
VIRX
980
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $5.99M | ﹤0.01% |
+646,820
| New | +$5.99M |
|
981
FTI Consulting
FCN
$5.26B
| $5.98M | ﹤0.01% |
42,700
+18,184
| +74% | +$2.55M |
|
982
Pan American Silver
PAAS
$15.3B
| $5.95M | ﹤0.01% |
198,327
+149,270
| +304% | +$4.48M |
|
983
OR Royalties Inc.
OR
$6.7B
| $5.92M | ﹤0.01% |
537,578
-14,745
| -3% | -$162K |
|
984
Arch Capital
ACGL
$33.7B
| $5.83M | ﹤0.01% |
152,033
-24,244
| -14% | -$930K |
|
985
Lamb Weston
LW
$7.81B
| $5.77M | ﹤0.01% |
74,526
+6,415
| +9% | +$497K |
|
986
KeyCorp
KEY
$21.1B
| $5.64M | ﹤0.01% |
282,469
-10,920
| -4% | -$218K |
|
987
Li Auto
LI
$24.3B
| $5.61M | ﹤0.01% |
+224,220
| New | +$5.61M |
|
988
PG&E
PCG
$33.8B
| $5.59M | ﹤0.01% |
477,735
+323,742
| +210% | +$3.79M |
|
989
NexGen Energy
NXE
$4.52B
| $5.57M | ﹤0.01% |
1,547,652
+419,039
| +37% | +$1.51M |
|
990
Camden Property Trust
CPT
$11.7B
| $5.57M | ﹤0.01% |
50,701
-524,226
| -91% | -$57.6M |
|
991
Amkor Technology
AMKR
$6.13B
| $5.56M | ﹤0.01% |
+234,420
| New | +$5.56M |
|
992
Northern Trust
NTRS
$24.2B
| $5.53M | ﹤0.01% |
52,585
+192
| +0.4% | +$20.2K |
|
993
Fortune Brands Innovations
FBIN
$7.07B
| $5.5M | ﹤0.01% |
67,125
-10,292
| -13% | -$843K |
|
994
Beyond Meat
BYND
$193M
| $5.5M | ﹤0.01% |
42,261
+10,159
| +32% | +$1.32M |
|
|
HES
995
DELISTED
Hess
HES
| $5.43M | ﹤0.01% |
76,708
-3,746
| -5% | -$265K |
|
996
Pacira BioSciences
PCRX
$1.19B
| $5.42M | ﹤0.01% |
+77,315
| New | +$5.42M |
|
997
American Well
AMWL
$106M
| $5.37M | ﹤0.01% |
15,470
+9,357
| +153% | +$3.25M |
|
998
Gartner
IT
$17.6B
| $5.32M | ﹤0.01% |
29,145
-5,039
| -15% | -$920K |
|
999
Xerox
XRX
$461M
| $5.25M | ﹤0.01% |
216,211
+206,049
| +2,028% | +$5M |
|
1000
Corcept Therapeutics
CORT
$7.53B
| $5.24M | ﹤0.01% |
220,358
+79,693
| +57% | +$1.9M |
|